Investigation on the corrosion inhibitive effect of 2H-pyrazole-triazole derivatives in acidic solutionLI, W; ZHAO, X; LIU, F et al.Materials and corrosion (1995). 2009, Vol 60, Num 4, pp 287-293, issn 0947-5117, 7 p.Article

Treatment of Scedosporiosis with Voriconazole : Clinical Experience with 107 PatientsTROKE, Peter; AGUIRREBENGOA, Koldo; ARTEAGA, Carmen et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 5, pp 1743-1750, issn 0066-4804, 8 p.Article

Heteroresistance of Cryptococcus gattii to FluconazoleVARMA, A; KWON-CHUNG, K. J.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2303-2311, issn 0066-4804, 9 p.Article

Penetration of Voriconazole, 1%, Eyedrops Into Human Aqueous Humor : A Prospective Open-Label StudyLAU, David; FEDINANDS, Mervyn; LEUNG, Lok et al.Archives of ophthalmology (1960). 2008, Vol 126, Num 3, pp 343-346, issn 0003-9950, 4 p.Article

Voriconazole Pharmacokinetics in Liver Transplant RecipientsJOHNSON, H. J; HAN, K; ROMKES, M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 852-859, issn 0066-4804, 8 p.Article

Pharmacokinetics of Intracameral Voriconazole InjectionSHEN, Ying-Cheng; WANG, Mei-Yen; WANG, Chun-Yuan et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2156-2157, issn 0066-4804, 2 p.Article

Voriconazole Use for Endemic Fungal Infections 7FREIFELD, Alison; PROIA, Laurie; ANDES, David et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 4, pp 1648-1651, issn 0066-4804, 4 p.Article

Effect of Calcineurin Inhibitors on Posaconazole Blood Levels as Measured by the MVista Microbiological AssayZHUANG, David; SMEDEMA, Melinda; LEMONTE, Ann et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 730-731, issn 0066-4804, 2 p.Article

Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole ProphylaxisBOSE, Prithviraj; PAREKH, Hiral D; HOLTER, Jennifer L et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 4, pp 1674-1675, issn 0095-1137, 2 p.Article

Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazoleGERBER, Bernhard; GUGGENBERGER, Roman; FASLER, David et al.Blood. 2012, Vol 120, Num 12, pp 2390-2394, issn 0006-4971, 5 p.Article

Human Tissue Distribution of VoriconazoleWEILER, Stefan; FIEGL, David; MACFARLAND, Róisín et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 2, pp 925-928, issn 0066-4804, 4 p.Article

RAPID DESENSITIZATION TO FLUCONAZOLE (DIFLUCAN)RANDOLPH, Chris; KAPLAN, Cynthia; FRASER, Barbara et al.Annals of allergy, asthma, & immunology. 2008, Vol 100, Num 6, pp 616-617, issn 1081-1206, 2 p.Article

A Reference Laboratory Experience of Clinically Achievable Voriconazole, Posaconazole, and Itraconazole Concentrations within the Bloodstream and Cerebral Spinal FluidWIEDERHOLD, Nathan P; PENNICK, Gennethel J; DORSEY, Sheryl A et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 424-431, issn 0066-4804, 8 p.Article

Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 GenotypeZONIOS, Dimitrios; YAMAZAKI, Hiroshi; MURAYAMA, Norie et al.The Journal of infectious diseases. 2014, Vol 209, Num 12, pp 1941-1948, issn 0022-1899, 8 p.Article

Posaconazole Serum Level on Day 2 Predicts Steady State Posaconazole Serum LevelGREEN, Myke R; WOOLERY, Joseph E.Therapeutic drug monitoring. 2012, Vol 34, Num 1, pp 118-119, issn 0163-4356, 2 p.Article

Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformansLEE, Hyeseung; KHANAL LAMICHHANE, Ami; GARRAFFO, H. Martin et al.Molecular microbiology (Print). 2012, Vol 84, Num 1, pp 130-146, issn 0950-382X, 17 p.Article

Fluconazole inhibits human adrenocortical steroidogenesis in vitroDER PAS, R. Van; HOFLAND, L. J; HOFLAND, J et al.Journal of endocrinology. 2012, Vol 215, Num 3, pp 403-412, issn 0022-0795, 10 p.Article

In Vitro Susceptibilities of Yeast Species to Fluconazole and Voriconazole as Determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) StudyHE WANG; MENG XIAO; HU, Zhi-Dong et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 12, pp 3952-3959, issn 0095-1137, 8 p.Article

Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to TherapySHIELDS, Ryan K; CLANCY, Cornelius J; BERMUDEZ, Christian et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 3, pp 1308-1311, issn 0066-4804, 4 p.Article

Treatment of Refractory Coccidioidomycosis With Voriconazole or PosaconazoleKIM, Michelle M; VIKRAM, Holenarasipur R; KUSNE, Shimon et al.Clinical infectious diseases. 2011, Vol 53, Num 11, pp 1060-1066, issn 1058-4838, 7 p.Article

Solubility of Triadimefon in Organic Solvents at Temperatures between (288.15 and 333.15) KYANG, Xu-Zhao; JUN WANG.Journal of chemical and engineering data (Print). 2010, Vol 55, Num 9, pp 3869-3871, issn 0021-9568, 3 p.Article

Increased Virulence of Zygomycetes Organisms Following Exposure to Voriconazole : A Study Involving Fly and Murine Models of ZygomycosisLAMARIS, Gregory A; BEN-AMI, Ronen; LEWIS, Russell E et al.The Journal of infectious diseases. 2009, Vol 199, Num 9, pp 1399-1406, issn 0022-1899, 8 p.Article

Prospective Open-Label Study of the Administration of Two-Percent Voriconazole Eye DropsAL-BADRIYEH, Daoud; LEUNG, Lok; ROYDHOUSE, Trent et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 3153-3155, issn 0066-4804, 3 p.Article

Paracoccidioidomycosis presenting in the U.KWALKER, S. L; PEMBROKE, A. C; LUCAS, S. B et al.British journal of dermatology (1951). 2008, Vol 158, Num 3, pp 624-626, issn 0007-0963, 3 p.Article

Evaluating a Mustard Root-Length Bioassay for Predicting Crop Injury from Soil Residual FlucarbazoneSZMIGIELSKI, Anna M; SCHOENAU, Jeff J; IRVINE, Al et al.Communications in soil science and plant analysis. 2008, Vol 39, Num 3-4, pp 413-420, issn 0010-3624, 8 p.Article